329 completed, 91 recruiting, 78 terminated, 64 unknown. 668 Phase 2, 136 Phase 1, 21 Phase 3.
Follow Neoplasms, Connective Tissue: new trials by email Literature Review of Neoplasms, Connective Tissue trials Research Report on Neoplasms, Connective Tissue
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor Pimicotinib, Tumor resection surgery - Tenosynovial Giant Cell Tumor, Diffuse | Phase 2 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 84 | 2027-10-01 | 2026-07-16 |
| Combination Immunotherapy Targeting Sarcomas Multiple sarcoma-specific CAR-T cells and sarcoma vaccines - Sarcoma, Osteoid Sarcoma | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 20 | 2027-07-01 | 2026-11-02 |
| Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas Sarcoma-specific CAR-T cells - Sarcoma, Osteoid Sarcoma | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 20 | 2027-06-01 | 2026-10-30 |
| A Phase 1/2 Study of CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to Treat Archive Sample Retrieval, Biospecimen Collection, pH Low Insertion Peptide-exatecan Conjugate CBX-12 - Recurrent Childhood Ewing Sarcoma, Recurrent Childhood Malignant Solid Neoplasm | Phase 1 / Phase 2 | Not yet recruiting | Children's Oncology Group | 79 | 2027-05-07 | 2026-09-22 |
| Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors Aldesleukin, Biospecimen Collection, Chest Radiography - Locally Advanced Gastrointestinal Stromal Tumor, Metastatic Gastrointestinal Stromal Tumor | Phase 2 | Not yet recruiting | Joal Beane | 59 | 2027-02-15 | 2026-10-13 |
| Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma DT-7012, Doxorubicin - Undifferentiated Pleomorphic Sarcoma (UPS), Dedifferentiated Liposarcoma (DDLPS) | Phase 2 | Not yet recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 80 | 2027-02-01 | 2026-09-15 |
| RAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCT LX-101 - Ewing Sarcoma | Phase 2 | Not yet recruiting | M.D. Anderson Cancer Center | 120 | 2027-02-01 | 2026-08-24 |
| Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor avutometinib capsule + defactinib tablet - MPNST (Malignant Peripheral Nerve Sheath Tumor) | Phase 2 | Not yet recruiting | Girish Dhall, MD | 25 | 2027-01-01 | 2026-10-28 |
| Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C, Biopsy Procedure, Biospecimen Collection - Metastatic Myxoid Liposarcoma, Metastatic Synovial Sarcoma | Phase 2 | Not yet recruiting | National Cancer Institute (NCI) | 42 | 2026-11-23 | 2026-09-25 |
| A Study of DCC-3014 to Evaluate the Efficacy, Safety, and Pharmacokinetics in Subjects With TGCT DCC-3014 - Tenosynovial Giant Cell Tumor | Phase 2 | Not yet recruiting | Ono Pharmaceutical Co., Ltd. | 18 | 2026-10-31 | 2026-09-22 |
| The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma High-dose Methotrexate - Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults | Phase 2 | Recruiting | Wake Forest University Health Sciences | 46 | 2026-10-31 | 2026-11-04 |
| NAC-REPAIR for Post-surgical Pain NAC, NAC 0mg/day (Placebo) - Carpal Tunnel Surgery, Trigger Finger Disorder | Phase 2 | Not yet recruiting | University of Arizona | 80 | 2026-10-15 | 2026-07-17 |
| A Legacy Study in Participants With Gastrointestinal Stromal Tumors (GIST) Velzatinib - Gastrointestinal Neoplasms | Phase 2 | Not yet recruiting | GlaxoSmithKline | 72 | 2026-10-13 | 2026-09-28 |
| A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma Lifileucel - Sarcoma, Soft Tissue Sarcoma (STS) | Phase 2 | Recruiting | Iovance Biotherapeutics, Inc. | 80 | 2026-10-02 | 2026-10-09 |
| Phase I/II Trial of Dinutuximab Beta in Combination With Irinotecan and Rapamycin in Pediatric, Adolescents and Adult Patients With Relapsed/Refractory Bone Tumors. Dinutuximab beta, Sirolimus and Irinotecan - Osteosarcomas, Bone Cancer | Phase 1 / Phase 2 | Not yet recruiting | University Hospital, Strasbourg, France | 89 | 2026-10-01 | 2026-10-01 |
| A Study to Assess Safety and Efficacy of SOT106 in Patients With LRRC15-positive Advanced Unresectable or Metastatic Osteosarcoma or Soft Tissue Sarcoma SOT106 - Osteosarcoma Metastatic, Soft Tissue Sarcoma (STS) | Phase 1 / Phase 2 | Not yet recruiting | SOTIO Biotech a.s. | 70 | 2026-09-30 | 2026-09-03 |
| Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial Psilocybin (high dose), Psilocybin (low dose), PEARL Therapy - Advanced Cancer, Stage IV Solid Tumor Cancer | Phase 2 | Not yet recruiting | University Health Network, Toronto | 46 | 2026-09-14 | 2026-10-15 |
| SBRT Combined With Reduced-Dose Anthracycline Chemotherapy and Toripalimab as Neoadjuvant Therapy for Localized High-Risk Undifferentiated Pleomorphic Sarcoma Toripalimab, Liposomal doxorubicin, Stereotactic body radiotherapy (SBRT) - Undifferentiated Pleomorphic Sarcoma (UPS) | Phase 2 | Not yet recruiting | Tianjin Medical University Cancer Institute and Hospital | 39 | 2026-09-01 | 2026-09-14 |
| Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma Cyclophosphamide, Fludarabine, Mesna - Pediatric Osteosarcoma | Phase 2 | Recruiting | St. Jude Children's Research Hospital | 41 | 2026-08-21 | 2026-11-03 |
| A Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib Velzatinib - Gastrointestinal Neoplasms | Phase 2 | Recruiting | GlaxoSmithKline | 24 | 2026-08-17 | 2026-10-01 |
Showing 20 of 668. Sign in to see all of them.
Osteosarcoma (210) · Sarcoma (205) · Gastrointestinal Stromal Tumors (134) · Sarcoma, Ewing (111) · Rhabdomyosarcoma (88) · Sarcoma, Synovial (66) · Neuroblastoma (62) · Neurofibrosarcoma (57) · Leiomyosarcoma (55) · Histiocytoma, Malignant Fibrous (54) · Liposarcoma (49) · Neuroectodermal Tumors, Primitive, Peripheral (46) · Chondrosarcoma (42) · Fibrosarcoma (39) · Ovarian Neoplasms (37)
Neoplasms by Histologic Type (667) · Neoplasms, Connective and Soft Tissue (664) · Neoplasms (638) · Neoplasms, Bone Tissue (281) · Sarcoma (223) · Neoplasms, Fibrous Tissue (181) · Neoplasms by Site (177) · Neoplasms, Nerve Tissue (161) · Neoplasms, Glandular and Epithelial (158) · Digestive System Diseases (155) · Digestive System Neoplasms (152) · Gastrointestinal Diseases (144) · Gastrointestinal Neoplasms (136) · Neoplasms, Muscle Tissue (135)
Imatinib Mesylate (44) · Doxorubicin (36) · Ifosfamide (30) · Cyclophosphamide (29) · Cisplatin (21) · Gemcitabine (20) · Radiotherapy (20) · Temozolomide (20) · Etoposide (19) · Specimen Handling (18) · Magnetic Resonance Spectroscopy (17) · Methotrexate (17) · Vincristine (17) · Filgrastim (16) · Sirolimus (16)
National Cancer Institute (NCI) (81) · M.D. Anderson Cancer Center (28) · Memorial Sloan Kettering Cancer Center (25) · Novartis Pharmaceuticals (19) · Children's Oncology Group (15) · Asan Medical Center (14) · European Organisation for Research and Treatment of Cancer - EORTC (14) · Sarcoma Alliance for Research through Collaboration (14) · Peking University People's Hospital (11) · Italian Sarcoma Group (9) · St. Jude Children's Research Hospital (9) · Eli Lilly and Company (8) · Centre Leon Berard (7) · Dana-Farber Cancer Institute (7) · Grupo Espanol de Investigacion en Sarcomas (7)
United States (393) · France (85) · China (63) · Canada (62) · Italy (62) · Germany (56) · Spain (55) · United Kingdom (53) · Netherlands (49) · Australia (46) · South Korea (35) · Belgium (34) · Poland (32) · Puerto Rico (22) · Japan (19)
Silvia Stacchiotti, MD (6) · AeRang Kim, MD, PhD (5) · Hedy Kindler (4) · Margaret von Mehren, MD (4) · Richard Gorlick, MD (4) · Yoon-Koo Kang, MD, PhD (4) · Antonio Casado (3) · Brian H. Kushner, MD (3) · Claudia Valverde (3)
PMID 31401903, PMID 19451433, PMID 22682017, PMID 27355533, PMID 30477937, PMID 31013172, PMID 32192573, PMID 32827353, PMID 34416158, PMID 11705489, PMID 12528778, PMID 12957454, PMID 15010069, PMID 15084390, PMID 15177491, PMID 15592836, PMID 15659504, PMID 16314647, PMID 16435380, PMID 16528479, PMID 16532433, PMID 16775235, PMID 17095209, PMID 17109446, PMID 17290057, PMID 17336054, PMID 17715389, PMID 18006112, PMID 18448563, PMID 18676758, PMID 18942073, PMID 19088049, PMID 19338063, PMID 19451429, PMID 20226028, PMID 20338746, PMID 20471824, PMID 20525721, PMID 20576718, PMID 20622000, PMID 20715156, PMID 20837357, PMID 20838998, PMID 20881264, PMID 20932656, PMID 20943374, PMID 21098399, PMID 21108325, PMID 21387287, PMID 21456006
U10CA180886 (22), U10CA098543 (14), U10CA032102 (10), 2023 (7), P30CA008748 (7), U10CA031946 (7), U10CA180821 (5), 2009 (4), 2015 (4), 2017 (4), P30CA014599 (4), P30CA033572 (4), UM1CA228823 (4), 2014 (3), 2018 (3)